ArtemiX develops a novel, patented drug delivery system for the local sustained release of
active drug intended to prevent stenosis of bypass surgery and arteriovenous fistula (AVF). Postoperative complications (stenosis, occlusions), occur in up to 50% of the cases, leading to intimal hyperplasia, lumen narrowing and access failure, associated with increased morbidity, mortality and healthcare costs.
ArtemiX intends to prevent vessel stenosis and increases the primary patency success rate.